Price comparison of the 10 most expensive drugs as of 2017

Per-year list price of the top ten most expensive drugs worldwide as of 2017

Price comparison of the 10 most expensive drugs as of 2017 This statistic displays the cost of the top ten most expensive drugs worldwide as of 2017. According to the data, orphan drugs for rare diseases make up the top ten most costly drugs worldwide in 2017. The number one most expensive drug was Ravicti or glycerol phenylbutyrate with a list price of over 793 thousand U.S. dollars per year. Ravicti is used in the long-term treatment of urea cycle disorders.
Show more

Per-year list price of the top ten most expensive drugs worldwide as of 2017

Loading statistic...
List price per year in U.S. dollars
Ravicti (glycerol phenylbutyrate)793,632$
Brineura (cerliponase alfa)702,000$
Lumizyme (alglucosidase alfa)626,400$
Carbaglu (carglumic acid)585,408$
Actimmune (interferon gamma 1-b)572,292$
Soliris (eculizumab)542,640$
Alprolix (coagulation factor IX recombinanc Fc fusion protein)503,880$
Idelvion (albutrepenonacog alfa)500,000$
Naglazyme (galsulfase)485,747$
Folotyn (pralatrexate)450,540$
List price per year in U.S. dollars
Ravicti (glycerol phenylbutyrate)793,632$
Brineura (cerliponase alfa)702,000$
Lumizyme (alglucosidase alfa)626,400$
Carbaglu (carglumic acid)585,408$
Actimmune (interferon gamma 1-b)572,292$
Soliris (eculizumab)542,640$
Alprolix (coagulation factor IX recombinanc Fc fusion protein)503,880$
Idelvion (albutrepenonacog alfa)500,000$
Naglazyme (galsulfase)485,747$
Folotyn (pralatrexate)450,540$
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic displays the cost of the top ten most expensive drugs worldwide as of 2017. According to the data, orphan drugs for rare diseases make up the top ten most costly drugs worldwide in 2017. The number one most expensive drug was Ravicti or glycerol phenylbutyrate with a list price of over 793 thousand U.S. dollars per year. Ravicti is used in the long-term treatment of urea cycle disorders.
Show more
Release date
May 2017
Region
Worldwide
Survey time period
as of May 2017
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Orphan drugs
Orphan drugs

All Information
in one Presentation

Orphan drugs

Everything On "Orphan drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Orphan drugs"
  • Market overview
The most important statistics
  • Companies
  • Products
  • Research and development
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.